Search

Your search keyword '"Gasperetti, Alessio' showing total 13 results
Start Over Author "Gasperetti, Alessio Journal international journal of cardiology
13 results on '"Gasperetti, Alessio'

1. Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience

Author

Migliore, Federico, Schiavone, Marco, Pittorru, Raimondo, Forleo, Giovanni B., De Lazzari, Manuel, Mitacchione, Gianfranco, Biffi, Mauro, Gulletta, Simone, Kuschyk, Jurgen, Dall'Aglio, Pietro Bernardo, Rovaris, Giovanni, Tilz, Roland, Mastro, Florinda Rosaria, Iliceto, Sabino, Tondo, Claudio, Di Biase, Luigi, Gasperetti, Alessio, Tarzia, Vincenzo, and Gerosa, Gino

Published
2024
Full Text
View/download PDF

2. Peri-procedural and mid-term follow-up age-related differences in leadless pacemaker implantation: Insights from a multicenter European registry

Author

Gulletta, Simone, Schiavone, Marco, Gasperetti, Alessio, Breitenstein, Alexander, Palmisano, Pietro, Mitacchione, Gianfranco, Chierchia, Gian Battista, Montemerlo, Elisabetta, Statuto, Giovanni, Russo, Giulia, Casella, Michela, Vitali, Francesco, Mazzone, Patrizio, Hofer, Daniel, Arabia, Gianmarco, Moltrasio, Massimo, Lipartiti, Felicia, Fierro, Nicolai, Bertini, Matteo, Dello Russo, Antonio, Pisanò, Ennio C.L., Biffi, Mauro, Rovaris, Giovanni, de Asmundis, Carlo, Tondo, Claudio, Curnis, Antonio, Della Bella, Paolo, Saguner, Ardan M., and Forleo, Giovanni B.

Published
2023
Full Text
View/download PDF

4. Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy

Author

Muscogiuri, Giuseppe, Fusini, Laura, Ricci, Francesca, Sicuso, Rita, Guglielmo, Marco, Baggiano, Andrea, Gasperetti, Alessio, Casella, Michela, Mushtaq, Saima, Conte, Edoardo, Annoni, Andrea, Formenti, Alberto, Mancini, Maria Elisabetta, Babbaro, Mario, Mollace, Rocco, Collevecchio, Ada, Scafuri, Stefano, Kukavica, Deni, Andreini, Daniele, Basso, Cristina, Rizzo, Stefania, De Gaspari, Monica, Priori, Silvia, Dello Russo, Antonio, Tondo, Claudio, Pepi, Mauro, Sommariva, Elena, Rabbat, Mark, Guaricci, Andrea Igoren, and Pontone, Gianluca

Published
2021
Full Text
View/download PDF

7. Cardiac surgeon and electrophysiologist shoulder-to-shoulder approach: Hybrid room, a kingdom for two. A zero mortality transvenous lead extraction single center experience

Author

Roberto, Maurizio, Sicuso, Rita, Manganiello, Sabrina, Catto, Valentina, Salvi, Luca, Nafi, Matteo, Casella, Michela, Rossi, Fabiana, Grillo, Francesco, Saccocci, Matteo, Gasperetti, Alessio, Cervellione, Rosario, Carcione, Davide, Alamanni, Francesco, Tondo, Claudio, and Dello Russo, Antonio

Published
2019
Full Text
View/download PDF

8. Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience

Author

Gianfranco Mitacchione, Spinello Antinori, Giosuè Mascioli, Antonio Curnis, Alessio Gasperetti, Massimo Mancone, Cecilia Gobbi, Marco Schiavone, Federica Sabato, Massimo Galli, Mattia Busana, and Giovanni B. Forleo

Subjects
medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Short Communication, Disease, heparin, 030204 cardiovascular system & hematology, coagulopathy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, oral anticoagulants, 030212 general & internal medicine, anticoagulation, Oral anticoagulation, microthrombosis, business.industry, Mortality rate, COVID-19, Heparin, 3. Good health, Radiological weapon, Cohort, Cardiology and Cardiovascular Medicine, business, medicine.drug, Cohort study
Abstract

Background Since the body of evidence addressing the coagulation derangements caused by Coronavirus disease (COVID-19) has been constantly growing, we investigated whether pre-hospitalization oral anticoagulation (OAC) or in-hospital heparin treatment could have a protective role among COVID-19 patients. Method In this cohort study, consecutive COVID-19 patients admitted to four different Italian Institutions were enrolled. Baseline demographic, clinical, laboratory, and radiological characteristics, as well as in-hospital treatment and outcomes were evaluated. The primary outcome was mortality. Results A total of 844 COVID-19 patients were enrolled as study cohort, n = 65 (7.7%) taking OACs prior to hospitalization. Regarding clinical outcomes, OAC patients developed acute hypoxemic respiratory failure (AHRF) more frequently than non-OAC patients as well as presenting a higher mortality rate (44.6% vs 19.8%, p, Highlights • Evidence on a prothrombotic asset caused by COVID-19 has been constantly growing. • In our cohort, OACs appeared to be ineffective in reducing mortality rate. • Heparin resulted to be a useful treatment when lung disease was sufficiently severe. • Microthrombosis may have a crucial role in COVID-19. • Due to the relatively small sample size of OAC patients included, larger studies are needed.

Published
2021
Full Text
View/download PDF

10. Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration

Author

Iacopo Olivotto, Alessio Gasperetti, and Mattia Targetti

Subjects
medicine.medical_specialty, medicine.diagnostic_test, Dose titration, business.industry, medicine.drug_class, Right ventricular cardiomyopathy, Text mining, Internal medicine, Cardiology, medicine, Anti arrhythmic, Cardiology and Cardiovascular Medicine, business, Electrocardiography, Beta blocker
Published
2021
Full Text
View/download PDF

12. Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience

Author

Schiavone, Marco, primary, Gasperetti, Alessio, additional, Mancone, Massimo, additional, Curnis, Antonio, additional, Mascioli, Giosuè, additional, Mitacchione, Gianfranco, additional, Busana, Mattia, additional, Sabato, Federica, additional, Gobbi, Cecilia, additional, Antinori, Spinello, additional, Galli, Massimo, additional, and Forleo, Giovanni Battista, additional

Published
2021
Full Text
View/download PDF

13. Reply to: Assessment of administering antithrombosis in COVID-19 patients with acute hypoxemic respiratory failure

Author

Cecilia Gobbi, Marco Schiavone, Mattia Busana, Alessio Gasperetti, and Giovanni B. Forleo

Subjects
medicine.medical_specialty, 2019-20 coronavirus outbreak, Acute hypoxemic respiratory failure, Coronavirus disease 2019 (COVID-19), business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 05 social sciences, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, 0502 economics and business, medicine, 050211 marketing, Cardiology and Cardiovascular Medicine, Intensive care medicine, business
Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results